Table 7 Correlation between GSMD and VEGF with Progression-free survival and Overall survival among malignant pleural effusion group
From: Role of GSDMD and VEGF in differentiating between malignant and non-malignant pleural effusions
Studied variables | Mean ± SD Median (months) | GSDMD | VEGF | ||
|---|---|---|---|---|---|
r | P value | r | P value | ||
Progression-free survival | 11.4 ± 2.85 12.0 | − 0.531 | 0.009* | − 0.582 | 0.006* |
Overall survival | 7.13 ± 3.93 6.00 | − 0.390 | 0.066 | − 0.304 | 0.181 |